CRISPR-话题@MedSci

#CRISPR#

417篇内容 | 4389人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276200, encodeId=b28912e620084, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Editas基于CRISPR-Cas12a的β-地贫疗法获FDA孤儿药认证, objectType=article, longId=727077, objectId=9be7e270778c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be7e270778c, replyNumber=0, likeNumber=96, createdTime=2022-05-18, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be7e270778c, moduleTitle=Editas基于CRISPR-Cas12a的β-地贫疗法获FDA孤儿药认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be7e270778c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276199, encodeId=2e3412e61998a, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature Biomedical Engineering: 用魔法打败魔法？利用RNA干扰降低CRISPR在肝脏中的脱靶性, objectType=article, longId=724367, objectId=a951e2436726, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a951e2436726, replyNumber=0, likeNumber=107, createdTime=2022-04-17, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a951e2436726, moduleTitle=Nature Biomedical Engineering: 用魔法打败魔法？利用RNA干扰降低CRISPR在肝脏中的脱靶性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a951e2436726)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276198, encodeId=ca3412e619846, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=张锋新论文：通过CRISPR激活筛选，发现癌症免疫治疗耐药性关键蛋白, objectType=article, longId=302086, objectId=cb4e3020863f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb4e3020863f, replyNumber=0, likeNumber=111, createdTime=2022-04-01, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb4e3020863f, moduleTitle=张锋新论文：通过CRISPR激活筛选，发现癌症免疫治疗耐药性关键蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb4e3020863f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276197, encodeId=5a9e12e619750, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature Biomedical Engineering：武汉大学殷昊团队开发基于CRISPR的新冠快检技术，20分钟内精准检测新冠病毒, objectType=article, longId=301541, objectId=2d7a30154160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d7a30154160, replyNumber=0, likeNumber=70, createdTime=2022-03-25, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d7a30154160, moduleTitle=Nature Biomedical Engineering：武汉大学殷昊团队开发基于CRISPR的新冠快检技术，20分钟内精准检测新冠病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d7a30154160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276196, encodeId=d08512e619612, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Cell子刊：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, objectType=article, longId=300611, objectId=b2bc30061145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2bc30061145, replyNumber=0, likeNumber=98, createdTime=2022-03-14, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2bc30061145, moduleTitle=Cell子刊：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2bc30061145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276195, encodeId=375e12e619527, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Cell Metabolism：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, objectType=article, longId=300540, objectId=a882300540f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a882300540f9, replyNumber=0, likeNumber=97, createdTime=2022-03-13, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a882300540f9, moduleTitle=Cell Metabolism：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a882300540f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276194, encodeId=bea112e619479, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Cell Research：舒易来等开发CRISPR/Cas9-HMEJ基因修复体系治疗隐性遗传性聋, objectType=article, longId=299835, objectId=824a299835f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=824a299835f0, replyNumber=0, likeNumber=93, createdTime=2022-03-02, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=824a299835f0, moduleTitle=Cell Research：舒易来等开发CRISPR/Cas9-HMEJ基因修复体系治疗隐性遗传性聋, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=824a299835f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276193, encodeId=155812e61937d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature Communications：意想不到：CRISPR基因编辑会导致可遗传的基因组结构突变, objectType=article, longId=295274, objectId=52592952e45c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52592952e45c, replyNumber=0, likeNumber=140, createdTime=2022-02-10, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52592952e45c, moduleTitle=Nature Communications：意想不到：CRISPR基因编辑会导致可遗传的基因组结构突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52592952e45c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276191, encodeId=49f812e619173, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Cell Reports：纳米颗粒助力，首次实现对血管内皮的CRISPR基因编辑, objectType=article, longId=293505, objectId=677a2935052c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677a2935052c, replyNumber=0, likeNumber=87, createdTime=2022-01-07, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677a2935052c, moduleTitle=Cell Reports：纳米颗粒助力，首次实现对血管内皮的CRISPR基因编辑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677a2935052c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276192, encodeId=79cb12e619201, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=STTT：高飞/李铮等揭示男性无精症致病基因，并通过CRISPR基因编辑进行修复, objectType=article, longId=293491, objectId=7c3f293491f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c3f293491f6, replyNumber=0, likeNumber=98, createdTime=2022-01-07, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c3f293491f6, moduleTitle=STTT：高飞/李铮等揭示男性无精症致病基因，并通过CRISPR基因编辑进行修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c3f293491f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276190, encodeId=10b412e61902f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=展望2022：受期待的11项临床试验，从CRISPR、裸盖菇素，到溶瘤病毒, objectType=article, longId=292584, objectId=014329258412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=014329258412, replyNumber=0, likeNumber=96, createdTime=2021-12-24, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=014329258412, moduleTitle=展望2022：受期待的11项临床试验，从CRISPR、裸盖菇素，到溶瘤病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=014329258412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276189, encodeId=cad312e61892b, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=“瑞士军刀”的双面性：CRISPR基因编辑存在潜在致癌风险, objectType=article, longId=221361, objectId=4eaa22136102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eaa22136102, replyNumber=0, likeNumber=88, createdTime=2021-12-02, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eaa22136102, moduleTitle=“瑞士军刀”的双面性：CRISPR基因编辑存在潜在致癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eaa22136102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276188, encodeId=954b12e6188de, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Commun：彻底治愈艾滋病的曙光：FDA首次批准CRISPR基因编辑治疗艾滋病人体临床试验, objectType=article, longId=217427, objectId=9ca421e42714, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ca421e42714, replyNumber=0, likeNumber=70, createdTime=2021-09-24, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ca421e42714, moduleTitle=Nat Commun：彻底治愈艾滋病的曙光：FDA首次批准CRISPR基因编辑治疗艾滋病人体临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ca421e42714)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276187, encodeId=bb2912e61871a, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215474, objectId=cc6f2154e469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6f2154e469, replyNumber=0, likeNumber=85, createdTime=2021-08-10, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6f2154e469, moduleTitle=NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc6f2154e469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276186, encodeId=cfa812e618666, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215363, objectId=58cb215363aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58cb215363aa, replyNumber=0, likeNumber=94, createdTime=2021-08-07, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58cb215363aa, moduleTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58cb215363aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276185, encodeId=9c1312e6185db, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=NEJM：开启医学新时代：体内CRISPR基因编辑临床试验结果公布，安全有效, objectType=article, longId=213372, objectId=036d2133e2b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036d2133e2b0, replyNumber=0, likeNumber=71, createdTime=2021-06-29, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036d2133e2b0, moduleTitle=NEJM：开启医学新时代：体内CRISPR基因编辑临床试验结果公布，安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036d2133e2b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276184, encodeId=8e1212e618440, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Commun：全基因组CRISPR筛选揭示乳腺癌的易感性和mTOR/Hippo协同潜在靶向治疗策略, objectType=article, longId=211956, objectId=28ac211956ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ac211956ff, replyNumber=0, likeNumber=77, createdTime=2021-05-29, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ac211956ff, moduleTitle=Nat Commun：全基因组CRISPR筛选揭示乳腺癌的易感性和mTOR/Hippo协同潜在靶向治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ac211956ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276183, encodeId=690112e61830d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature：体内CRISPR基因编辑技术助力永久降血脂, objectType=article, longId=211580, objectId=c67d211580d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67d211580d0, replyNumber=0, likeNumber=71, createdTime=2021-05-22, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67d211580d0, moduleTitle=Nature：体内CRISPR基因编辑技术助力永久降血脂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67d211580d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276182, encodeId=464c12e618279, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Science Translational Medicine：代替吗啡治疗疼痛的依赖！基于CRISPR和锌指蛋白的基因治疗技术缓解慢性疼痛, objectType=article, longId=208881, objectId=ee422088811c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee422088811c, replyNumber=0, likeNumber=94, createdTime=2021-03-25, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee422088811c, moduleTitle=Science Translational Medicine：代替吗啡治疗疼痛的依赖！基于CRISPR和锌指蛋白的基因治疗技术缓解慢性疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee422088811c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276181, encodeId=524012e6181c3, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Science：CRISPR基因沉默机制开拓慢性疼痛新疗法, objectType=article, longId=208298, objectId=5913208298df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5913208298df, replyNumber=0, likeNumber=94, createdTime=2021-03-13, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5913208298df, moduleTitle=Science：CRISPR基因沉默机制开拓慢性疼痛新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5913208298df)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CRISPR

2020-05-29

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Editas基于CRISPR-Cas12a的β-地贫疗法获FDA孤儿药认证

2022-05-18

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Nature Biomedical Engineering: 用魔法打败魔法？利用RNA干扰降低CRISPR在肝脏中的脱靶性

2022-04-17

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

张锋新论文：通过CRISPR激活筛选，发现癌症免疫治疗耐药性关键蛋白

2022-04-01

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Nature Biomedical Engineering：武汉大学殷昊团队开发基于CRISPR的新冠快检技术，20分钟内精准检测新冠病毒

2022-03-25

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Cell子刊：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段

2022-03-14

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Cell Metabolism：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段

2022-03-13

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Cell Research：舒易来等开发CRISPR/Cas9-HMEJ基因修复体系治疗隐性遗传性聋

2022-03-02

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Nature Communications：意想不到：CRISPR基因编辑会导致可遗传的基因组结构突变

2022-02-10

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

Cell Reports：纳米颗粒助力，首次实现对血管内皮的CRISPR基因编辑

2022-01-07

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

STTT：高飞/李铮等揭示男性无精症致病基因，并通过CRISPR基因编辑进行修复

2022-01-07

docwu2019 (审核中...)

前往app查看评论内容

#CRISPR#

展望2022：受期待的11项临床试验，从CRISPR、裸盖菇素，到溶瘤病毒

2021-12-24

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

“瑞士军刀”的双面性：CRISPR基因编辑存在潜在致癌风险

2021-12-02

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Commun：彻底治愈艾滋病的曙光：FDA首次批准CRISPR基因编辑治疗艾滋病人体临床试验

2021-09-24

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-10

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-07

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

NEJM：开启医学新时代：体内CRISPR基因编辑临床试验结果公布，安全有效

2021-06-29

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Commun：全基因组CRISPR筛选揭示乳腺癌的易感性和mTOR/Hippo协同潜在靶向治疗策略

2021-05-29

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature：体内CRISPR基因编辑技术助力永久降血脂

2021-05-22

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Science Translational Medicine：代替吗啡治疗疼痛的依赖！基于CRISPR和锌指蛋白的基因治疗技术缓解慢性疼痛

2021-03-25

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Science：CRISPR基因沉默机制开拓慢性疼痛新疗法

2021-03-13

科室
- - 订阅+
  - 更多科室
工具
服务